Skip to content
Disclosery

JOHNSON & JOHNSON

Follow

13F filer, CIK 200406, NEW BRUNSWICK, NJ

JOHNSON & JOHNSON reported $555,047,952 across 17 holdings for the quarter ended 2025-12-31, in a 13F-HR/A filed 2026-03-18. Its ten largest share positions make up 98.34% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0000904454-26-000192

Period
2025-12-31
Reported value
$555M
Holdings
17
Top 10 weight
98.34%
New
2
Sold out
5

Part of the filer group JOHNSON & JOHNSON

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VORnew+53,732$703K
ACETnew+22,779$192K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARWRexited-247,598-$8.54M
VOR BIOPHARMA INCexited-53,732-$2.62M
CVRXreduced-78,569-$558K
ADICET BIO INCexited-364,472-$295K
BIOMX INCexited-96,866-$50.9K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR/A 0000904454-26-000192, largest first. % of portfolio is the value over $555,047,952, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,449,183 shares; 2024Q4: 2,449,183 shares; 2025Q1: 2,449,183 shares; 2025Q2: 2,449,183 shares; 2025Q3: 2,449,183 shares; 2025Q4: 2,449,183 shares 2,449,183$214M38.54%0Timeline
NBTXNANOBIOTIXQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,623,816 shares; 2024Q4: 5,623,816 shares; 2025Q1: 5,623,816 shares; 2025Q2: 5,623,816 shares; 2025Q3: 5,623,816 shares; 2025Q4: 5,623,816 shares 5,623,816$130M23.43%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,498,051 shares; 2024Q4: 2,498,051 shares; 2025Q1: 2,498,051 shares; 2025Q2: 2,498,051 shares; 2025Q3: 1,784,517 shares; 2025Q4: 1,784,517 shares 1,784,517$54.1M9.75%0Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,641,064 shares; 2024Q4: 6,641,064 shares; 2025Q1: 6,641,064 shares; 2025Q2: 6,641,064 shares; 2025Q3: 6,641,064 shares; 2025Q4: 6,641,064 shares 6,641,064$52.8M9.51%0Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,103,430 shares; 2024Q4: 4,103,430 shares; 2025Q1: 4,103,430 shares; 2025Q2: 4,103,430 shares; 2025Q3: 4,103,430 shares; 2025Q4: 4,024,861 shares 4,024,861$28.6M5.15%-78,569Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,979,173 shares; 2024Q4: 1,979,173 shares; 2025Q1: 1,979,173 shares; 2025Q2: 1,979,173 shares; 2025Q3: 1,979,173 shares; 2025Q4: 1,979,173 shares 1,979,173$22.6M4.08%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 814,586 shares; 2024Q4: 814,586 shares; 2025Q1: 814,586 shares; 2025Q2: 814,586 shares; 2025Q3: 814,586 shares; 2025Q4: 814,586 shares 814,586$17.7M3.19%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 748,062 shares; 2024Q4: 748,062 shares; 2025Q1: 748,062 shares; 2025Q2: 748,062 shares; 2025Q3: 748,062 shares; 2025Q4: 748,062 shares 748,062$11.5M2.06%0Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 357,939 shares; 2024Q4: 357,939 shares; 2025Q1: 357,939 shares; 2025Q2: 357,939 shares; 2025Q3: 357,939 shares; 2025Q4: 357,939 shares 357,939$11.3M2.03%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,379,064 shares; 2024Q4: 3,379,064 shares; 2025Q1: 3,379,064 shares; 2025Q2: 3,379,064 shares; 2025Q3: 3,379,064 shares; 2025Q4: 3,379,064 shares 3,379,064$3.32M0.6%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,849,445 shares; 2024Q4: 1,849,445 shares; 2025Q1: 1,849,445 shares; 2025Q2: 1,849,445 shares; 2025Q3: 1,849,445 shares; 2025Q4: 1,849,445 shares 1,849,445$3.31M0.6%0Timeline
RALLYBIO CORPRALLYBIO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,636,363 shares; 2024Q4: 3,636,363 shares; 2025Q1: 3,636,363 shares; 2025Q2: 3,636,363 shares; 2025Q3: 3,636,363 shares; 2025Q4: 3,636,363 shares 3,636,363$2.49M0.45%0
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 54,887 shares; 2025Q4: 54,887 shares 54,887$1.69M0.3%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,732 shares 53,732$703K0.13%newTimeline
NNOXNANO X IMAGING LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 158,852 shares; 2024Q4: 158,852 shares; 2025Q1: 158,852 shares; 2025Q2: 158,852 shares; 2025Q3: 158,852 shares; 2025Q4: 158,852 shares 158,852$445K0.08%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 311,967 shares; 2024Q4: 311,967 shares; 2025Q1: 311,967 shares; 2025Q2: 311,967 shares; 2025Q3: 311,967 shares; 2025Q4: 311,967 shares 311,967$399K0.07%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,779 shares 22,779$192K0.03%newTimeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ARWRARROWHEAD PHARMACEUTICALS IN247,598$8.54Mshares
VOR BIOPHARMA INCVOR BIOPHARMA INC53,732$2.62Mshares
ADICET BIO INCADICET BIO INC364,472$295Kshares
BIOMX INCBIOMX INC96,866$50.9Kshares
SENSEONICS HLDGS INCSENSEONICS HLDGS INC54,621$23.8Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-26-000111 superseded2026-02-13acceptance time not in the bulk data set
13F-HR/A 0000904454-26-000192 baserestatement2026-03-18acceptance time not in the bulk data set